Thu.Aug 29, 2024

article thumbnail

Psilocybin Mushrooms: A Journey from Ancient Traditions to Modern Clinical Use

Drug Topics

As research continues to uncover the potential benefits of psilocybin, pharmacists and other clinicians have an essential role in bridging ancient wisdom with contemporary science.

179
179
article thumbnail

Efgartigimod Alfa Provides Much-Needed Treatment Options for Patients With Generalized Myasthenia Gravis

Pharmacy Times

Pharmacists can provide extra resources for patients, including explanations of the therapy options for the patients, the course of therapy, and what patients can expect.

149
149
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

California, nation’s largest milk producer, discloses possible bird flu outbreaks in three dairy cow herds

STAT

On Thursday, the California Department of Food and Agriculture announced it is investigating the possible introduction of H5N1 bird flu in cattle at three dairy farms in the Central Valley. If confirmed, they would be the first known cases in that state. In a statement, officials said testing of samples from the three farms is currently underway in the state’s veterinary diagnostic lab.

145
145
article thumbnail

Patients With Asthma Experience Changes in Airway Inflammation Following Electronic Cigarette Use

Pharmacy Times

Using 1 nicotine-containing electronic cigarette was significantly correlated with an increase in residual volume and total lung capacity in patients with asthma.

139
139
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

STAT+: The weight loss drug shortage is driving patients to Hims. What happens when the shortage ends?

STAT

Hims & Hers, one of the largest publicly traded telehealth companies in the country, has supercharged its business in the last several months by offering compounded versions of the patented weight loss drugs known as GLP-1s. It’s staking its future on the drugs, with plans to continue selling compounded GLP-1s even when shortages of the versions approved by regulators come to an end — a strategy that policy experts say could land the company in court.

article thumbnail

Treatment Approaches for Patients With Graft-Vs-Host Disease May Require Flexibility

Pharmacy Times

Pharmacists support treatment adherence as well as monitor adverse effects, drug-drug interactions, and quality of life.

132
132

More Trending

article thumbnail

Study: Researchers Find New Drug Target to Treat RSV

Pharmacy Times

The findings further the understanding of respiratory virus immune evasion mechanisms and uncover how RSV-NS1 can target therapeutic intervention

article thumbnail

Rep. Comer threatens PBM execs with fines, jail time over 'fraudulent' hearing testimony

Fierce Healthcare

A key legislator is accusing the leaders of the three largest pharmacy benefit managers of making fraudulent statements during a hearing last month on the industry. | A key legislator is accusing the leaders of the three largest pharmacy benefit managers of making fraudulent statements during a hearing last month on the industry.

125
125
article thumbnail

Switching asthma inhalers could reduce carbon emissions, says study

STAT

Concerns over health care’s carbon footprint typically revolve around issues like overly-air-conditioned hospitals and single-use medical supply waste.  But researchers like Stanford University’s Jyothi Tirumalasetty think that asthma inhalers are also a good place to start when it comes to reducing emissions. Metered-dose inhalers, the most common type used to treat asthma or chronic obstructive pulmonary disease (COPD), use a propellant gas to aerosolize medications, which p

Hospitals 124
article thumbnail

Q&A: Opill Ushers in New Era of Access to Birth Control

Drug Topics

Stephanie Sober, MD, MSHP, investigator on the pivotal research that supported the prescription-to-OTC switch of Opill, shares insights on how the medicine is reshaping the reproductive landscape.

123
123
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Study: Children With First Dose of Measles Vaccine May Not Receive Both Globally

Pharmacy Times

Pharmacists can help facilitate more organized efforts to improve measles vaccination uptake for children aged 5 and younger by identifying socio-demographic gaps within this population.

Vaccines 121
article thumbnail

AbbVie's Ubrelvy wards off migraines when used in reaction to early warning signs: study

Fierce Pharma

Despite competing against several drugs that have been approved to fend off migraine headaches, AbbVie’s Ubrelvy (ubrogepant) —which is approved only to treat them—has carved out a significant nich | Recent trial results indicate that AbbVie's migraine treatment Ubrelvy works as a preventative. In a study published this week in the journal Neurology, Ubrelvy was 73% more effective in preventing a migraine attack than placebo.

119
119
article thumbnail

Pharmacy Focus- Oncology Edition: Delayed Breast Cancer Screenings

Pharmacy Times

Expert shares reasons why many women are behind on their annual breast cancer screenings, along with the latest cutting edge treatments in the breast cancer space.

121
121
article thumbnail

Genentech is shedding even more employees

STAT

Want to stay on top of the science and politics driving biotech today?  Sign up  to get our biotech newsletter in your inbox. Hey there. We await one of the year’s biggest biotech readouts, and have lots of GLP-1 news today: Eli Lilly’s offer to slash pricing for Zepbound isn’t as magnanimous as it appears, and more.

118
118
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

Elation Health rolls out AI scribing tool embedded in its EHR for primary care docs

Fierce Healthcare

As artificial intelligence tools make their way into hospitals and doctor's offices, Elation Health saw a big opportunity to leverage its expertise in building clinical-first tech to roll out AI pu | As artificial intelligence tools make their way into hospitals and doctor's offices, Elation Health saw a big opportunity to leverage its expertise in building clinical-first tech to roll out AI purpose-built for primary care doctors.

Hospitals 116
article thumbnail

Opinion: Conversations about improving prenatal care must include transgender and gender diverse birthing people

STAT

I dreamed of having children from a young age — so much so that I assumed I had to be a cisgender woman. Society had taught me that only a cisgender woman would want so badly to carry and birth a child, so I suppressed any feelings that suggested I might not be a cisgender woman. I did not realize I was transgender until well after I had my children.

114
114
article thumbnail

Push for self-injected drugs prompts Novartis/Lindy alliance

pharmaphorum

Novartis partners with startup Lindy in a near-$1bn deal to develop subcutaneous formulations of biologic drugs

110
110
article thumbnail

Is famotidine safe during pregnancy?

The Checkup by Singlecare

Heartburn is incredibly common during pregnancy, especially in the second and third trimesters. If you find yourself dreading that churning, burning feeling before every meal, don’t fret. Pregnancy-safe treatments and remedies, such as famotidine (commonly known by its brand names Pepcid AC and Zantac 360 ), can help. Famotidine belongs to a class of medications called histamine-2 receptor antagonists ( H2 blockers for short).

Dosage 105
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Women's health DTx developer Curio raises funds for PPD app

pharmaphorum

Digital health firm Curio raises $10m+ in first-round financing that will be used to fund the rollout of its MamaLift Plus app for postpartum depression

105
105
article thumbnail

Pharma Pulse 8/29/24: Talkspace and PTPA Join Forces, Digital Medicines Information & more

Pharmaceutical Commerce

The latest news for pharma industry insiders.

105
105
article thumbnail

Neurocrine slides as schizophrenia data disappoints

pharmaphorum

Shares in Neurocrine Biosciences took a tumble after it reported mid-stage data for a key pipeline drug for schizophrenia that failed to impress investors

105
105
article thumbnail

HDA 2024 Traceability Seminar: A Legal Perspective Regarding DSCSA

Pharmaceutical Commerce

Panel offers suggestions on how compliance teams should be considering handling SOPs, stabilization, and much more.

101
101
article thumbnail

GSK gets EU okay for RSV shot in younger age group

pharmaphorum

GSK gets EU approval for its RSV vaccine Arexvy in a younger age group, a potential leg-up in a market tussle with Pfizer and Moderna

Vaccines 105
article thumbnail

HHS reverses course, will no longer appeal federal court's hospital web tracker decision

Fierce Healthcare

The Department of Health and Human Services (HHS) is dropping its appeal of a June U.S. | The department's white flag came 10 days after the administration had filed its appeal of the June decision to the Fifth Circuit.

article thumbnail

Drug repositioning to bring forgotten assets from shelves to patients

pharmaphorum

Learn about drug repositioning, a strategy that involves finding new uses for existing drugs. Discover how this approach brings forgotten assets from shelves to patients and contributes to drug development.

98
article thumbnail

Dupixent face rash and redness: Causes and treatment

The Checkup by Singlecare

Around 1 in 10 Americans have some type of eczema , which means 10% of the country deals with dry, itchy, inflamed, scaly skin or lesions. Dupixent (dupilumab) is a biologic monoclonal antibody medication that can help treat moderate-to-severe atopic dermatitis (AD), as well as asthma, chronic rhinosinusitis, and nasal polyps. Although it can relieve some of this skin disease’s most irritating symptoms, dupilumab treatment may also cause side effects, specifically a facial rash and facial erythe

article thumbnail

Bayer takes lung cancer therapy hope into phase 3

pharmaphorum

Bayer takes oral anti-HER2 drug into phase 3 for HER2-altered lung cancer, a key pillar of its drive to become a major player in oncology

97
article thumbnail

API maker Global Calcium stung with Form 483 filing after FDA inspection of Indian plant

Fierce Pharma

Active pharmaceutical ingredient maker Global Calcium has run afoul of FDA investigators on the heels of a recent inspection of the company’s factory in the Indian State of Tamil Nadu. | Following an inspection that ran from July 29 to Aug. 2, the FDA handed API maker Global Calcium a six-observation Form 483. The FDA’s writeup covers a range of production infractions, ranging from incomplete batch records and poorly followed manufacturing procedures to subpar testing and poor facility upkeep.

FDA 96
article thumbnail

A journey from deep depression to mental health advocacy

pharmaphorum

Follow along on a journey from deep depression to mental health advocacy, discovering ways to cope and support others along the way.

96
article thumbnail

The most expensive drugs in the US

Pharmaceutical Technology

From Orchard’s Lenmeldy to Vertex and CRISPR Therapeutics’s Casgevy, Pharmaceutical Technology lists the top ten priciest therapies in the US.

95
article thumbnail

STAT+: Thoughts, takes, and burning biotech questions as the beginning of the end of the year approaches

STAT

This is the online edition of Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can sign up  here  to get it delivered to their inbox. Labor Day is almost here, which means the sprint to the end of 2024 is upon us.  If you’re reading this late-August newsletter from the beach, the pool, or the mountains, I thank you for it.

91
article thumbnail

Desperately need something for a headache or diarrhoea? Good luck trying to find a pharmacy | Nell Frizzell

The Guardian - Pharmaceutical Industry

For years we’ve been told to use pharmacies rather than GPs whenever possible. The would be fine – if so many of them hadn’t closed down Until I’d woken up in the middle of an orchard at 2am with a child so covered in bites it was like trying to share a tent with a bag of feral cats, I hadn’t quite realised the extent of the pharmacy shortage in the UK.

90
article thumbnail

Jim Wilson’s next venture, a surprise startup shutdown, & Lilly’s Zepbound strategy

STAT

What’s behind the “great abandonment” in gene therapy R&D? How does a startup spend $213 million? And is Adam an optimist? We talk about all that and more on this week’s episode of “The Readout LOUD.” STAT biotech reporter Jonathan Wosen joins us to discuss gene therapy pioneer Jim Wilson’s exit from his decades-long tenure at the University of Pennsylvania.

91